PredictWallStreet - The Stock Prediction Community

News Story

Research Report Identifies TTM Technologies, Zumiez, Global Net Lease, Catabasis Pharmaceuticals, BioPharmX, and Protalix BioTherapeutics with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

Apr 12, 2019

NEW YORK, April 12, Apr 12, 2019 (GLOBE NEWSWIRE via COMTEX News Network) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of TTM Technologies, Inc. (NASDAQ:TTMI), Zumiez Inc. (NASDAQ:ZUMZ), Global Net Lease, Inc. (NYSE:GNL), Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), BioPharmX Corporation (NYSE:BPMX), and Protalix BioTherapeutics, Inc. (NYSE:PLX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

TTMI DOWNLOAD: http://MarketSourceResearch.com/register/?so=TTMI

ZUMZ DOWNLOAD: http://MarketSourceResearch.com/register/?so=ZUMZ

GNL DOWNLOAD: http://MarketSourceResearch.com/register/?so=GNL

CATB DOWNLOAD: http://MarketSourceResearch.com/register/?so=CATB

BPMX DOWNLOAD: http://MarketSourceResearch.com/register/?so=BPMX

PLX DOWNLOAD: http://MarketSourceResearch.com/register/?so=PLX

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine TTM Technologies, Inc. (NASDAQ:TTMI), Zumiez Inc. (NASDAQ:ZUMZ), Global Net Lease, Inc. (NYSE:GNL), Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), BioPharmX Corporation (NYSE:BPMX), and Protalix BioTherapeutics, Inc. (NYSE:PLX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

TTM TECHNOLOGIES, INC. (TTMI) REPORT OVERVIEW

TTM Technologies' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, TTM Technologies reported revenue of $710.96MM vs $739.35MM (down 3.84%) and analysts estimated basic earnings per share $0.51 vs $0.48 (up 6.25%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, TTM Technologies reported revenue of $2,847.26MM vs $2,658.59MM (up 7.10%) and analysts estimated basic earnings per share $1.68 vs $1.22 (up 37.70%). Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.09. The estimated EPS forecast for the next fiscal year is $0.80 and is expected to report on February 5th, 2020.

To read the full TTM Technologies, Inc. (TTMI) report, download it here: http://MarketSourceResearch.com/register/?so=TTMI

-----------------------------------------

ZUMIEZ INC. (ZUMZ) REPORT OVERVIEW

Zumiez's Recent Financial Performance

For the three months ended January 31st, 2019 vs January 31st, 2018, Zumiez reported revenue of $304.56MM vs $308.25MM (down 1.19%) and analysts estimated basic earnings per share $1.18 vs $0.81 (up 45.68%). For the twelve months ended January 31st, 2019 vs January 31st, 2018, Zumiez reported revenue of $978.62MM vs $927.40MM (up 5.52%) and analysts estimated basic earnings per share $1.81 vs $1.09 (up 66.06%). Analysts expect earnings to be released on June 6th, 2019. The report will be for the fiscal period ending April 30th, 2019. Reported EPS for the same quarter last year was -$0.10. The estimated EPS forecast for the next fiscal year is $1.96 and is expected to report on March 12th, 2020.

To read the full Zumiez Inc. (ZUMZ) report, download it here: http://MarketSourceResearch.com/register/?so=ZUMZ

-----------------------------------------

GLOBAL NET LEASE, INC. (GNL) REPORT OVERVIEW

Global Net Lease's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Global Net Lease reported revenue of $71.23MM vs $66.60MM (up 6.94%) and analysts estimated basic earnings per share -$0.10 vs $0.08. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Global Net Lease reported revenue of $282.21MM vs $259.30MM (up 8.84%) and analysts estimated basic earnings per share $0.01 vs $0.30 (down 96.67%). Analysts expect earnings to be released on May 14th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.49. The estimated EPS forecast for the next fiscal year is $2.08 and is expected to report on February 26th, 2020.

To read the full Global Net Lease, Inc. (GNL) report, download it here: http://MarketSourceResearch.com/register/?so=GNL

-----------------------------------------

CATABASIS PHARMACEUTICALS, INC. (CATB) REPORT OVERVIEW

Catabasis Pharmaceuticals' Recent Financial Performance

Analysts expect earnings to be released on May 9th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$2.90. The estimated EPS forecast for the next fiscal year is -$2.35 and is expected to report on March 12th, 2020.

To read the full Catabasis Pharmaceuticals, Inc. (CATB) report, download it here: http://MarketSourceResearch.com/register/?so=CATB

-----------------------------------------

BIOPHARMX CORPORATION (BPMX) REPORT OVERVIEW

BioPharmX's Recent Financial Performance

For the three months ended January 31st, 2019 vs January 31st, 2018, BioPharmX reported revenue of $0.01MM vs $0.02MM (down 73.68%) and analysts estimated basic earnings per share -$0.03 vs -$0.01. For the twelve months ended January 31st, 2019 vs January 31st, 2018, BioPharmX reported revenue of $0.06MM vs $0.07MM (down 21.92%) and analysts estimated basic earnings per share -$0.09 vs -$0.19. Analysts expect earnings to be released on June 6th, 2019. The report will be for the fiscal period ending April 30th, 2019. The reported EPS for the same quarter last year was -$0.02. The estimated EPS forecast for the next fiscal year is -$0.03 and is expected to report on March 12th, 2020.

To read the full BioPharmX Corporation (BPMX) report, download it here: http://MarketSourceResearch.com/register/?so=BPMX

-----------------------------------------

PROTALIX BIOTHERAPEUTICS, INC. (PLX) REPORT OVERVIEW

Protalix BioTherapeutics' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Protalix BioTherapeutics reported revenue of $10.35MM vs $4.31MM (up 140.49%) and analysts estimated basic earnings per share -$0.03 vs -$0.07. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Protalix BioTherapeutics reported revenue of $34.24MM vs $21.08MM (up 62.44%) and analysts estimated basic earnings per share -$0.18 vs -$0.64. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.06. The estimated EPS forecast for the next fiscal year is $0.35 and is expected to report on March 16th, 2020.

To read the full Protalix BioTherapeutics, Inc. (PLX) report, download it here: http://MarketSourceResearch.com/register/?so=PLX

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst(R) (CFA(R)) designations and FINRA(R) BrokerCheck(R) certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content thataEUR(TM)s ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA(R) charterholders, licensed securities attorneys, and registered FINRA(R) members holding duly issued CRD(R) numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:

Jim Patterson, Media Department

Office: +1 (704) 343-6361

E-mail: media@MarketSourceResearch.com

(C) 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

FINRA(R), BrokerCheck(R), and CRD(R) are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

__GNW8366DE3E__IMG

(C) Copyright 2019 GlobeNewswire, Inc. All rights reserved.

SOURCE: Comtex

Tweet Radar

-ALLSYMB- OTLK
Scroll over any stock symbol to predict whether that stock’s value will go up or down and to view other valuable community sentiment content.

Click on any stock symbol to see what people are tweeting about it.

Make a Prediction

Find & Follow
Top Predictors

Join Contests